The improving effects of Saengmaeksan on ulcerative colitis |
Kim, Min-Cheol
(Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude)
Kim, Su-Jin (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Choi, In-Young (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Ki, Ji-Ye (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Kim, Dae-Seung (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Jeon, Yong-Deok (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Bae, Go-Eun (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Choi, Sun-Kyung (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) Jeong, Hyun-Ja (Biochip Research Center, Hoseo University) Park, Yun-Jum (Division of Horticulture and Pet Animal-Plant Science, Wonkwang University) Kim, Hyung-Min (Department of Pharmacology, College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University) Um, Jae-Young (Department of Pharmacology, College of Oriental Medicine, Institute of Oriental Medicine, Kyung Hee University) Hong, Seung-Heon (Department of Oriental Pharmacy, College of Pharmacy, VestibuloCochlear Research Center of Wonkwang University, Wonkwang Oriental Medicines Research Institude) |
1 | Rufo PA, Bousvaros A. (2006) Current therapy of inflammatory bowel disease in children. Paediatr. Drugs 8, 279-302. DOI ScienceOn |
2 | Sato K, Ohkura S, Kitahara Y, Ohama T, Hori M, Sato M, Kobayashi S, Sasaki Y, Hayashi T, Nasu T, Ozaki H. (2007) Involvement of CPI-17 downregula in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model. Neurogastroenterol. Motil. 19, 504-514. DOI ScienceOn |
3 | Schaecher K, Goust JM, Banik NL. (2004) The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem. Res. 29, 1443-1451. DOI ScienceOn |
4 | Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. (2003) Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125, 1311-1319. DOI ScienceOn |
5 | Wei YL, Li YJ, Liu X. (2001) Experimental study of protective effect of shenmai injection on endotoxin induced systemic inflammatory reaction syndrome and multiple organ dysfunction syndrome. Zhongguo Zhong Xi Yi Jie He Za Zhi 21, 47-50. |
6 | Yadav SK, Lee SC. (2006) Evidence for Oldenlandia diffusa-evoked cancer cell apoptosis through superoxide burst and caspase activation. Zhong Xi Yi Jie He Xue Bao 4, 485-489. DOI |
7 | Zhang YC, Chen RM, Lu BJ, Rong YZ. (2008) Effect of Shengmai Injection on cardiac function and inflammatory reaction in patients with acute coronary syndrome. Chin J Integr Med 14, 107-110. DOI ScienceOn |
8 | Fan H, Qiu MY, Mei JJ, Shen GX, Liu SL, Chen R. (2005) Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis. World J. Gastroenterol. 11, 4800-4806. DOI |
9 | Fiocchi C. (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115, 182-205. DOI ScienceOn |
10 | Ghosh S, May MJ, Kopp EB. (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260. DOI ScienceOn |
11 | Hendrickson BA, Gokhale R, Cho JH. (2002) Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev. 15, 79-94. DOI |
12 | Hyams JS. (2000) Inflammatory bowel disease. Pediatr. Rev. 21, 291-295. DOI |
13 | Jeong HJ, Na HJ, Hong SH, Kim HM. (2003) Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 144, 4080-4086. DOI ScienceOn |
14 | Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ. (2010) Disease-Related Expression of the IL-6/STAT3/SOCS3 Signaling Pathway in Ulcerative Colitis and Ulcerative Colitis-Related Carcinogenesis. Gut 59, 227-235. DOI ScienceOn |
15 | Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38, 1722-1734. DOI |
16 | Barnes PJ, Karin M. (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 336, 1066-1071. DOI ScienceOn |
17 | Neurath MF, Pettersson S, Meyer zum Büschenfelde KH, Strober W. (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat. Med. 2, 998-1004. DOI ScienceOn |
18 | Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702. DOI |
19 | Ardizzone S, Bianchi PG. (2005) Biologic therapy for inflammatory bowel disease. Drugs 65, 2253-2286. DOI ScienceOn |
20 | Blumberg RS, Saubermann LJ, Strober W. (1999) Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.Curr. Opin. Immunol. 11, 648-656. DOI ScienceOn |
21 | Danese S, Sans M, Fiocchi C. (2004) Inflammatory bowel disease: the role of environmental factors. Autoimmun. Rev. 3, 394-400. DOI ScienceOn |
22 | Domenech E. (2006) Inflammatory bowel disease: current therapeutic options. Digestion 73, 67-76. DOI ScienceOn |